Haematologica
(Jul 2025)
A retrospective study of isatuximab-pomalidomide-dexamethasone in relapsed/refractory systemic AL amyloidosis
- Sargam Rachit Vohra,
- Sriram Ravichandran,
- Darren Foard,
- Ana Martinez-Naharro,
- Lucia Venneri,
- Marianna Fontana,
- Carol J. Whelan,
- Philip N. Hawkins,
- Julian Gillmore,
- Helen J. Lachmann,
- Shameem Mahmood,
- Ashutosh D. Wechalekar
Affiliations
- Sargam Rachit Vohra
- National Amyloidosis Centre, UCL (Royal Free Campus), London
- Sriram Ravichandran
- National Amyloidosis Centre, UCL (Royal Free Campus), London
- Darren Foard
- National Amyloidosis Centre, UCL (Royal Free Campus), London
- Ana Martinez-Naharro
- National Amyloidosis Centre, UCL (Royal Free Campus), London
- Lucia Venneri
- National Amyloidosis Centre, UCL (Royal Free Campus), London
- Marianna Fontana
- National Amyloidosis Centre, UCL (Royal Free Campus), London
- Carol J. Whelan
- National Amyloidosis Centre, UCL (Royal Free Campus), London
- Philip N. Hawkins
- National Amyloidosis Centre, UCL (Royal Free Campus), London
- Julian Gillmore
- National Amyloidosis Centre, UCL (Royal Free Campus), London
- Helen J. Lachmann
- National Amyloidosis Centre, UCL (Royal Free Campus), London
- Shameem Mahmood
- National Amyloidosis Centre, UCL (Royal Free Campus), London
- Ashutosh D. Wechalekar
- National Amyloidosis Centre, UCL (Royal Free Campus), London
- DOI
-
https://doi.org/10.3324/haematol.2025.287664
- Journal volume & issue
-
Vol. 999,
no. 1
WeChat QR code
